Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    20381283 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Conditions: Embolism and Thrombosis;   Embolism;   Vascular Diseases;   Warfarin;   Venous Thromboembolism;   Thrombosis;   Thromboembolism
Intervention: Other: CYP 2C9 and VKORC1 Testing for Warfarin
2 Recruiting Diagnosing Adverse Drug Reactions Registry
Condition: Genetics of Drug Metabolism
Intervention:

Indicates status has not been verified in more than two years